Sandoz Sets Forth On Quest To Raise Its Margins

Sandoz is set to undergo a transformation in terms of operational efficiency, geographic footprint and portfolio offering in a bid to lift its operating margin from the mid-teens range towards 20%.

Margin
Sandoz is undertaking a range of transformational intitiatives aimed at improving its profit margins • Source: Shutterstock

Beset by fierce competition and price erosion in its core generics business, particularly in the US, Novartis’ Sandoz division is undertaking an ambitious transformational shift that the group believes will deliver sustainable growth at considerably improved profit margins.

A concerted effort to streamline its manufacturing base and optimize supply-chain efficiency is already underway, contributing in 2018 to a...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Earnings

More from Business